Pubblicazioni

A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast Cancer

2021 - CURRENT ONCOLOGY

Piras, Marta; Panebianco, Martina; Garibaldi, Matteo; Roberto, Michela; Merlonghi, Gioia; Pellegrini, Patrizia; Marchetti, Paolo

SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab

2017 - MEDICAL ONCOLOGY

Meattini, Icro; Curigliano, Giuseppe; Terziani, Francesca; Becherini, Carlotta; Airoldi, Mario; Allegrini, Giacomo; Amoroso, Domenico; Barni, Sandro; Bengala, Carmelo; Guarneri, Valentina; Marchetti, Paolo; Martella, Francesca; Piovano, Pierluigi; Vannini, Agnese; Desideri, Isacco; Tarquini, Roberto; Galanti, Giorgio; Barletta, Giuseppe; Livi, Lorenzo

Current challenges in HER2-positive breast cancer

2016 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Puglisi, Fabio; Fontanella, Caterina; Amoroso, Vito; Bianchi, Giulia Valeria; Bisagni, Giancarlo; Falci, Cristina; Fontana, Andrea; Generali, Daniele; Gianni, Lorenzo; Grassadonia, Antonio; Moscetti, Luca; Portarena, Ilaria; Rossi, Emanuela; Marchetti, Paolo

Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients

2016 - TUMOR BIOLOGY

DE IULIIS, Francesca; Salerno, Gerardo; Taglieri, Ludovica; DE BIASE, Luciano; Lanza, Rosina; Cardelli, Patrizia; Scarpa, Susanna